| [1] |
Molitch ME. Diagnosis and treatment of pituitary adenomas[J]. JAMA, 2017, 317(5): 516-524.
doi: 10.1001/jama.2016.19699
pmid: 28170483
|
| [2] |
Melmed S. Pituitary-tumor endocrinopathies[J]. N Engl J Med, 2020, 382(10): 937-950.
doi: 10.1056/NEJMra1810772
URL
|
| [3] |
Fleseriu M, Auchus R, Bancos I, et al. Consensus on diagnosis and management of Cushing’s disease[J]. Lancet Diabetes Endocrinol, 2021, 9(12): 847-875.
doi: 10.1016/S2213-8587(21)00235-7
URL
|
| [4] |
Reincke M, Sbiera S, Hayakawa A, et al. Mutations in the deubiquitinase gene USP8 cause Cushing’s disease[J]. Nat Genet, 2015, 47(1): 31-38.
doi: 10.1038/ng.3166
pmid: 25485838
|
| [5] |
Ma ZY, Song ZJ, Chen JH, et al. Recurrent gain-of-function USP8 mutations in Cushing’s disease[J]. Cell Res, 2015, 25(3): 306-317.
doi: 10.1038/cr.2015.20
|
| [6] |
Castellnou S, Vasiljevic A, Lapras V, et al. SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors[J]. Endocr Connect, 2020, 9(3): 243-253.
doi: 10.1530/EC-20-0035
URL
|
| [7] |
Chen J, Jian X, Deng S, et al. Identification of recurrent USP48 and BRAF mutations in Cushing’s disease[J]. NNat Commun, 2018, 9(1): 3171.
|
| [8] |
Hernández-Ramírez LC, Gam R, Valdés N, et al. Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease[J]. Endocr Relat Cancer, 2017, 24(8): 379-392.
doi: 10.1530/ERC-17-0131
URL
|
| [9] |
Schernthaner-Reiter MH, Trivellin G, Stratakis CA. MEN1, MEN4, and carney complex: pathology and molecular genetics[J]. Neuroendocrinology, 2016, 103(1): 18-31.
doi: 10.1159/000371819
pmid: 25592387
|
| [10] |
Chasseloup F, Pankratz N, Lane J, et al. Germline CDKN1B loss-of-function variants cause pediatric Cushing’s disease with or without an MEN4 phenotype[J]. J Clin Endocrinol Metab, 2020, 105(6): 1983-2005.
doi: 10.1210/clinem/dgaa160
URL
|
| [11] |
Mete O, Lopes MB. Overview of the 2017 WHO classification of pituitary tumors[J]. Endocr Pathol, 2017, 28(3): 228-243.
doi: 10.1007/s12022-017-9498-z
pmid: 28766057
|
| [12] |
Asa SL, Mete O, Perry A, et al. Overview of the 2022 WHO classification of pituitary tumors[J]. Endocr Pathol, 2022, 33(1): 6-26.
doi: 10.1007/s12022-022-09703-7
pmid: 35291028
|
| [13] |
WHO Classification of Tumours Editorial Board. WHO classification of endocrine and neuroendocrine tumours[M]. Lyon: IARC Press, 2022.
|
| [14] |
Reincke M, Theodoropoulou M. Genomics in Cushing’s disease: the dawn of a new era[J]. J Clin Endocrinol Metab, 2021, 106(6): e2455-e2456.
doi: 10.1210/clinem/dgaa969
pmid: 33524136
|
)
